Latest research highlights from the eight EURION projects
On 28 January 2021 the highlights on the activities and results from each of the eight EURION Cluster projects were presented. The projects are developing new testing and screening methods to identify endocrine disrupting chemicals (EDCs). To learn more about these innovative projects and hear their latest research activities, please watch the videos of the Project Highlights recorded at the EURION Cluster Annual Meeting in January 2021.
Annual forum on Endocrine disruptors (17-18 December 2020)
The European Commission is organising the second Annual Forum on Endocrine Disruptors on 17-18 December 2020.
The Forum will bring together scientists, policy makers, public and private stakeholders with expertise on endocrine disruptors to exchange information and best practices, identify challenges and build synergies, in order to inform the Commission’s reflections.
The programme will include presentations on the latest state of science and human health protection, on national action plans on endocrine disruptors, and on the European Commission’s work on the fitness check to assess whether relevant EU legislation on endocrine disruptors delivers its overall objective to protect human health and the environment.
This Forum is one of the actions in the Commission COMMUNICATION of November 2018 « Towards a comprehensive European Union Framework on Endocrine Disruptors », outlining a strategic approach to endocrine disruptors for the years to come, with the ultimate goal of ensuring a high level of protection of EU citizens and the environment as well as to preserve an internal market.
This year EURION will be organising an informative session on 17 December 2020.
Please note that this is an online conference and there is no fee for this event. If you don’t have an existing Funding and Tender Opportunities Portal account then please create one by clicking here.
Registration Deadline: 11 December 2020
Sept 2020: EURION Stakeholders Consultation on test methods for endocrine disruptors
European Cluster to Improve Identification of Endocrine Disruptors, EURION, kindly asks for your input to a first, general scanning of stakeholders’ interests, needs and priorities for the development of test methods for endocrine disruptors (EDs).
EURION (https://eurion-cluster.eu) is a cluster of eight European research projects, funded under EU’s Horizon 2020 framework. The projects are focusing on the development of new ED test methods targeting relevant endpoints that are not sufficiently covered by current regulatory tests.
As a stakeholder of the EURION cluster projects, you are invited to provide your opinion on the most important criteria to be considered for the development of these tests. Your contribution will be critical to allow us to know your views and, ultimately, to develop new tests that are applicable and useful for hazard assessment of EDs. Results of the survey will be presented and discussed at a stakeholder workshop taking place 19 October 2020 (in Brussels or via a digital platform), and for which you will be invited.
Please note that we will handle your data in accordance with the privacy legislation, the General Data Protection Regulation (GDPR) of the EU. The results of the survey will be published without linking them to any personal information. By filling in the questionnaire and submitting it online, you confirm that you have read this information and agree that the information given in the questionnaire may be used for EURION Cluster purposes, including presentations and exchange among relevant stakeholders as well as potential related materials, papers and reports.
Please answer the short (5-10 min) questionnaire by 15 Ocotber 2020 via this link: https://forms.gle/rmxBhfzG7NypTT727
on behalf of the EURION Cluster,
ENDpoiNTs and ERGO Coordination team.
13 Jan 2020: Prof. Barbara Demeneix in the Financial Times
A letter of Prof. Barbara Demeneix in the Financial Times discusses that chemical pollution is affecting the brain development of future generations often implicating endocrine disruption of epigenetic processes.
24 Aug 2019: ENDpoiNTs at International Neurotoxicology Association (INA)
ENDpoiNTs presented at the 17th biannual meeting of the International Neurotoxicology Association (INA), Sept. 29 – Oct. 3 2019, Dusseldorf, Germany. The ENDpoiNTs coordinator and various other researchers presented recent research in the ENDpoiNTs session on “Novel Testing Strategies for Endocrine Disruptors linked to Developmental Neurotoxicity”. Testing strategies based on in vitro batteries, sex-dependent effects of EDCs on hippocampus, to novel approaches to identify neurotoxic modes of action, and endocrine disruption in human neurodevelopmental models were discussed.